Diagnosis and Management of Adult Fasting Low Blood Sugar and Insulinoma at the National Institutes of Health

What this Trial Is About

This research aims to understand the causes and treatment of fasting hypoglycemia, including conditions like insulinomas and other pancreatic neuroendocrine tumors. The study focuses on gathering knowledge about the disease mechanisms and identifying new biomarkers to improve diagnosis and therapy. It also plans to build a clinical data and sample repository for future insulinoma research. Participants will be admitted to the Clinical Center of the National Institutes of Health for evaluation and treatment based on their specific condition and standard care practices. During the study, patients will undergo tests including fasting blood sugar measurements, insulin level assessments, and other diagnostic procedures related to insulin secretion. Medical and surgical care will be provided as needed under supervision. Throughout participation, patients will be monitored regularly every 1 to 3 months to assess treatment outcomes. The study involves blood tests and clinical evaluations to track progress and response to therapy. Participants can expect thorough medical supervision and repeated assessments to better understand their condition over time.

Diagnosing and Treating Low Blood Sugar Levels